• 1
    Lunzer M, Barnes P, Byth K, O'Halloran M. Serum bile acid concentrations during pregnancy and their relationship to obstetric cholestasis. Gastroenterology 1986; 91: 825829.
  • 2
    Lammert F, Marschall HU, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 2000; 33: 10121021.
  • 3
    Davies MH, Da Silva RCMA, Jones SR, Weaver JB, Elias E. Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid. Gut 1995; 37: 580584.
  • 4
    Johnston WG, Baskett TF. Obstetric cholestasis: a 14 year review. Am J Obstet Gynecol 1979; 133: 299301.
  • 5
    Fisk NM, Storey GN. Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol 1988; 95: 11371143.
  • 6
    Reyes H. Review: intrahepatic cholestasis: a puzzling disorder of pregnancy. J Gastroenterol Hepatol 1997; 12: 211216.
  • 7
    FlemingPJ, LeachC, BlairPS, SmithIJ, Ward-PlattMP, OldhamJ, et al., eds. Study of Antepartum Term Stillbirths. Confidential Enquiry Into Stillbirths and Deaths in Infancy Studies. UK 5th Annual Report. London: The Stationary Office 1995; 4150.
  • 8
    Kenyon AP, Piercy CN, Girling J, Williamson C, Tribe RM, Shennan AH. Pruritus may precede abnormal liver function tests in pregnant women with obstetric cholestasis: a longitudinal analysis. Br J Obstet Gynaecol 2001; 108: 11901192.
  • 9
    Kenyon AP, Girling J, Nelson-Piercy C, Williamson C, Seed PT, Poston L, et al. Pruritus in pregnancy and the identification of those at risk of obstetric cholestasis: a prospective prevalence study of 6531 women [Abstract]. J Soc Gynecol Invest 2002; 9: 671A.
  • 10
    Roger D, Vaillant L, Fignon A, Pierre F, Bacq Y, Brechot JF, et al. Specific pruritic diseases of pregnancy: a prospective study of 3192 pregnant women. Arch Dermatol 1994; 130: 734739.
  • 11
    Hayes PC, Hussey AJ, Keating J, Bouchier IA, Williams R, Beckett GJ, et al. Glutathione S-transferase levels in autoimmune chronic active hepatitis: a more sensitive index of hepatocellular damage than aspartate transaminase. Clin Chim Acta 1988; 172: 211216.
  • 12
    Beckett GJ, Hayes JD. Glutathione S-transferases: biomedical applications. Adv Clin Chem 1993; 30: 281380.
  • 13
    Knapen MF, Peters WH, Mulder TP, Steegers EA. A marker for hepatocellular damage. Lancet 2000; 355(9213): 14631464.
  • 14
    Girling JC, Dow E, Smith JH. Liver function tests in pre-eclampsia: importance of comparison with a reference range derived for normal pregnancy. Br J Obstet Gynaecol 1997; 104: 246250.
  • 15
    Amemiya T. Tobit models: a survey. J Econ 1984; 11: 247258.
  • 16
    Huber PJ. The behaviour of maximum likelihood estimates under non-standard conditions. In: Proceedings of the Fifth Berkeley Symposium in Mathematical Statistics and Probability. Berkeley, CA: University of California Press, 1967: 221233.
  • 17
    Corrigall AV, Kirsch RE. Glutathione S-transferase distribution and concentration in human organs. Biochem Int 1988; 16: 443448.
  • 18
    Knapen MF, Mulder TP, Bisseling JG, Penders RH, Peters WH, Steegers EA. Plasma glutathione S-transferase alpha 1-1: a more sensitive marker for hepatocellular damage than serum alanine aminotransferase in hypertensive disorders of pregnancy. Am J Obstet Gynecol 1998; 178: 161165.
  • 19
    Mulder TP, Peters WH, Court DA, Jansen JB. Sandwich ELISA for glutathione S-transferase alpha 1-1: plasma concentrations in controls and in patients with gastrointestinal disorders. Clin Chem 1996; 42: 416419.
  • 20
    Heikkinen J, Maentausta O, Ylostalo P, Janne O. Changes in serum bile acid concentrations during normal pregnancy, in patients with intrahepatic cholestasis of pregnancy and in pregnant women with itching. Br J Obstet Gynaecol 1981; 88: 240245.
  • 21
    Laatikainen T, Ikonen E. Serum bile acids in cholestasis of pregnancy. Obstet Gynecol 1977; 50: 313318.
  • 22
    Fisk NM, Bye WB, Storey GN. Maternal features of obstetric cholestasis: 20 years experience at King George V Hospital. Aust N Z J Obstet Gynaecol 1988; 28: 172176.
  • 23
    Knapen MF, Wong WY, Mulder TP, Peters WH, Merkus HM, Steegers EA. Umbilical cord plasma glutathione S-transferase alpha 1-1 levels as a marker of neonatal hepatocellular integrity. Obstet Gynecol 1998; 91: 490494.
  • 24
    Palmer DG, Eads J. Intrahepatic cholestasis of pregnancy: a critical review. J Perinat Neonatal Nurs 2000; 14: 3951.
  • 25
    Heikkinen J. Serum bile acids in the early diagnosis of intrahepatic cholestasis of pregnancy. Obstet Gynecol 1983; 61: 581587.
  • 26
    Bacq Y, Sapey T, Brechot MC, Pierre F, Fignon A, Dubois F. Intrahepatic cholestasis of pregnancy: a French prospective study. HEPATOLOGY 1997; 26: 358364.
  • 27
    Rioseco AJ, Ivankovic MB, Manzur A, Hamed F, Kato SR, Parer JT, et al. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 1994; 170: 890895.
  • 28
    Lopez J, Glasinovic JC, Marinovic I, Vela P, Ahumada E, Valdivia MT, et al. [ Clinical and laboratory characterization in 100 cases of pregnancy cholestasis]. Rev Chil Obstet Ginecol 1982; 47: 215221.
  • 29
    Ylostalo P, Ylikorkala O. Itching during pregnancy. Ann Chir Gynaecol Fenn 1975; 64: 123127.
  • 30
    Samuelson K, Thomassen PA. Radioimmunoassay of serum bile acids in normal pregnancy and in recurrent cholestasis of pregnancy. Acta Obstet Gynecol Scand 1980; 59: 417420.
  • 31
    Alberty R, Albertyova D. Biological variability of twenty-five serum analytes during normal pregnancy. Clin Chim Acta 1993; 214: 245248.
  • 32
    Davidson KM. Intrahepatic cholestasis of pregnancy. Semin Perinatol 1998; 22: 104111.
  • 33
    Lammert F, Marschall HU, Matern S. Intrahepatic cholestasis of pregnancy. Curr Treat Options Gastroenterol 2003; 6: 123132.
  • 34
    Laatikainen T, Tulenheimo A. Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. Int J Gynaecol Obstet 1984; 22: 9194.
  • 35
    Heikkinen J, Ylostalo P, Maentausta O, Janne O. Bile acids in maternal serum, umbilical cord serum and amniotic fluid of healthy women, women with pruritis and patients with intrahepatic cholestasis of pregnancy. J Obstet Gynaecol 1983; 4: 1720.
  • 36
    Milkiewicz P, Gallagher R, Chambers J, Eggington E, Weaver J, Elias E. Obstetric cholestasis with elevated gamma glutamyl transpeptidase: incidence, presentation and treatment. J Gastroenterol Hepatol 2003; 18: 12831286.
  • 37
    Dixon PH, Weerasekera N, Linton KJ, Donaldson O, Chambers J, Egginton E, et al. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet 2000; 9: 12091217.
  • 38
    Ch'ng CL, Morgan M, Hainsworth I, Kingham JGC. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002; 51: 876880.
  • 39
    Jacquemin E, Hadchouel M, Congard B, Laugier J. [ Cholestasis in pregnancy and normal serum gammaglutamyl transpeptidase activity]. Gastroenterol Clin Biol 1988; 12: 768769.
  • 40
    Savander M, Ropponen A, Avela K, Weerasekera N, Cormand B, Hirvioja ML, et al. Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy. Gut 2003; 52: 10251029.
  • 41
    Brites D, Rodrigues CM, van Zeller H, Brito A, Silva R. Relevance of serum bile acid profile in the diagnosis of intrahepatic cholestasis of pregnancy in an high incidence area: Portugal. Eur J Obstet Gynecol Reprod Biol 1998; 80: 3138.
  • 42
    Reyes H. The enigma of intrahepatic cholestasis of pregnancy: lessons from Chile. HEPATOLOGY 1982; 2: 8796.
  • 43
    Forkman B, Ganrot PO, Gennser G, Rannevik G. Plasma protein pattern in recurrent cholestasis of pregnancy. Scand J Clin Lab Invest 1972; 124( Suppl): 8996.